SERB SA
7 products tracked · names used in filings: SERB SA, SERB SAS
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Amifampridine SERB amifampridine | Authorised | 2022-05-19 |
| 🇪🇺 | Amversio betaine anhydrous | Authorised | 2022-05-05 |
| 🇪🇺 | Voraxaze glucarpidase | Authorised | 2022-01-11 |
| 🇪🇺 | Idefirix imlifidase | Authorised | 2020-08-25 |
| 🇪🇺 | Xermelo telotristat ethyl | Authorised | 2017-09-17 |
| 🇪🇺 | Firdapse (previously Zenas) amifampridine | Authorised | 2009-12-23 |
| 🇪🇺 | Cyanokit hydroxocobalamin | Authorised | 2007-11-23 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.